Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 1 Hypoxia 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Positron Emission Tomography Computed Tomography 1 Ferrosoferric Oxide 1 Atovaquone 1 3-(4-(2-fluoroethoxy)phenyl)-2-(3-methyl-2-(4-((2-sulfamoylbenzo(d)thiazol-6-yloxy)methyl)-1H-1,2,3-triazol-1-yl)butanamido)propanoic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Hypoxia × Atovaquone × Clear all

NCT02628080 2019-09-04

ATOM

University of Oxford

Phase EARLY_PHASE1 Completed

Hypoxia, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡